Company Analysis

Alexandria Real Estate (ARE): The Bull Case — Why the Worst May Already Be Priced In

Daniel / March 15, 2026

The Contrarian Setup Let me lay out the bear case for Alexandria Real Estate first, because it’s important to acknowledge

Daniel / January 28, 2025

Welcome back to our ongoing analysis of Emergent BioSolutions (NYSE: EBS). As we enter Q4 2024, the company has made

Daniel / August 15, 2024

Hey there, fellow value investors! It’s time to dive into one of the companies I’ve been keeping a close eye

First Name

Last Name

Email address

Leave this field empty if you're human:

Scroll to Top